Skip to main content
. 2013 Oct 18;3:2984. doi: 10.1038/srep02984

Figure 3. Sequence logo of (A) first ten residues of N-terminus and (B) last ten residues of C-terminus of anticancer peptides where size of residue is proportional to its propensity.

Figure 3